Clinical Trial Update: Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma

View source ↗

Summary

Clinical trial examining a watch-and-wait strategy after immunochemotherapy for locally recurrent nasopharyngeal carcinoma; recruitment has not begun yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Recurrent Nasopharyngeal Carcinoma | Status: NOT_YET_RECRUITING